MARK MAZAK: Open Payments
NPI 1285748897 · LAKEWOOD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,125 in 69 payments from 17 companies in 2025. Trend: 2023 $7,378 · 2024 $2,249 · 2025 $2,125
Food & beverage: $1,284Consulting: $750Education: $91
| Company | Payments | Amount |
|---|---|---|
| Journey Medical Corporation | 1 | $750 |
| ABBVIE INC. | 24 | $234 |
| Janssen Biotech, Inc. | 2 | $180 |
| UCB, Inc. | 6 | $161 |
| Amgen Inc. | 2 | $157 |
| Galderma Laboratories, L.P. | 3 | $129 |
| E.R. Squibb & Sons, L.L.C. | 6 | $98 |
| Novartis Pharmaceuticals Corporation | 5 | $91 |
| Organon LLC | 6 | $89 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $64 |
Products named: TREMFYA, Bimzelx, Otezla, NEMLUVIO, SKYRIZI, RINVOQ, Sotyktu, VTAMA.
Industry payments across NJ — which companies pay providers there.
